Add to Calendar 11/4/2021 9:30:00 AM 11/4/2021 12:00:00 PM Digital Health Impact 2021

November 4, 2021              9:30 AM - 12 PM ET
The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities or collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients. Free virtual event
Virtual,
Founder & Chief Executive Officer, Bio-Conscious Technologies Inc.
Amir has a diverse background in developing novel medical software technology. Amir developed a novel technology to predict and prevent chronic disease complications using machine learning techniques. Amir has presented this technology at the 78th, 79th, and 80th, American Diabetes Association Scientific summits and is actively contributing to the science of glucose monitoring and how this data can be used to predict the onset of glucose-based conditions for patients with diabetes and pre-diabetes.

Brought to you by